» Authors » Hsieh-Chih Tsai

Hsieh-Chih Tsai

Explore the profile of Hsieh-Chih Tsai including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 95
Citations 696
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen P, Liao T, Chou C, Chu C, Hsiao P, Tsai H
Int J Med Sci . 2025 Mar; 22(5):1167-1175. PMID: 40027186
Postoperative scarring can significantly impact physical function, aesthetic outcomes, and overall quality of life. Effective scar management is crucial to mitigate these effects. This study aimed to compare the efficacy...
2.
Huang C, Wu T, Chen Y, Chou H, Wang J, Chuang K, et al.
ACS Appl Mater Interfaces . 2025 Jan; 17(4):6887-6900. PMID: 39828983
With increasing energy demands, the need for coating materials with exceptional superhydrophobic properties has grown substantially. However, the widespread use of fluorinated compounds, solvents, and polymer-based synthetic materials has led...
3.
Ahmed Y, Loukanov A, Tsai H
Adv Healthc Mater . 2024 Dec; :e2403743. PMID: 39723689
Porous polymers, including hydrogels, covalent organic frameworks (COFs), and hyper crosslinked polymers (HCPs), have become essential in biomedical research for their tunable pore architectures, large surface areas, and functional versatility....
4.
Kitaw S, Ahmed Y, Candra A, Wu T, Anley B, Chen Y, et al.
Nanoscale . 2024 Nov; 17(1):508-519. PMID: 39569603
The controlled synthesis of Ag/Au nanocomposite particles has remained a significant challenge in nanomaterial research. This study presents the synthesis, characterization, and surface-enhanced Raman scattering (SERS) performance of silver (Ag)...
5.
Chuang S, Chen K, Cheng Y, Chen Y, Lin S, Chou H, et al.
Int J Biol Macromol . 2024 Sep; 280(Pt 3):135894. PMID: 39322160
Glioblastoma multiforme (GBM) is an aggressive and common brain tumor. The blood-brain barrier prevents several treatments from reaching the tumor. This study proposes a Chemo-Immunotherapy synergy treatment chemically crosslinked hydrogel...
6.
Darge H, Addisu K, Tsai H, Birhan Y, Hanurry E, Mekonnen T, et al.
ACS Omega . 2024 Aug; 9(32):34268-34280. PMID: 39157138
Stimuli-responsive polymeric micelles decorated with cancer biomarkers represent an optimal choice for drug delivery applications due to their ability to enhance therapeutic efficacy while mitigating adverse side effects. Accordingly, we...
7.
Gebrie H, Thankachan D, Tsai H, Lai J, Chang H, Wu S
Colloids Surf B Biointerfaces . 2024 Jun; 241:114028. PMID: 38905811
Biotin receptors are overexpressed in various cancer cell types, essential in tumor development, metabolism, and metastasis. Chemotherapeutic agents may be more effective and have fewer adverse effects if they specifically...
8.
Wu T, Huang C, Tsai H, Lin T, Chen P, Darge H, et al.
Biomater Adv . 2023 Dec; 156:213722. PMID: 38101076
Noninvasive lung drug delivery is critical for treating respiratory diseases. Pluronic-based copolymers have been used as multifunctional materials for medical and biological applications. However, the Pluronic F127-based hydrogel is rapidly...
9.
Chen Y, Harn H, Hong Z, Huang Y, Lin Y, Zheng H, et al.
Eur J Pharm Sci . 2023 Oct; 191:106608. PMID: 37832855
Exosome therapy is a novel trend in regeneration medicine. However, identifying a suitable biomarker that can associate the therapeutic efficacy of exosomes with SCA3/MJD is essential. In this study, parental...
10.
Candra A, Darge H, Ahmed Y, Saragi I, Kitaw S, Tsai H
Int J Biol Macromol . 2023 Sep; 253(Pt 3):126869. PMID: 37703976
Biomaterials that are mediocre for cell adhesion have been a concern for medical purposes. In this study, we fabricated nano‑gold chitosan-bacterial cellulose (CBC-Au) via a facile in-situ method using spent...